Albumin paclitaxel Clinical Trials
3 recruitingDrug
Phase 23Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 2
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
Immunotherapy Esophagus Cancer
Fuzhou General Hospital93 enrolled1 locationNCT05515315
Recruiting
Phase 2Phase 3
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
ChemotherapyOral Squamous Cell CarcinomaNeoadjvant Therapy+1 more
Shanghai Jiao Tong University School of Medicine80 enrolled1 locationNCT05125055
Recruiting
Phase 2
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
Oral Squamous Cell Carcinoma
Weijia Fang, MD30 enrolled1 locationNCT05862168